Modulation of multidrug resistance protein (MRP1/ABCC1) expression: a novel physiological role for ouabain

R C Valente1, L S Capella, C R Nascimento

  • 1Instituto de Bioquímica Médica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.

Insights

The hormone ouabain affects the expression and function of the ATP binding cassette C1 (ABCC1) transporter. This hormonal regulation suggests a role for ABCC1 in body volume control and potential implications for cancer treatment.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Endocrinology

Background:

  • Ouabain, a (Na(+),K(+))-ATPase inhibitor, modulates ATP binding cassette (ABC) transporters like ABCC7, ABCB1, and ABCC1.
  • ABCB1 is the only ABC transporter with a known physiological role in the kidney, involved in secretion.
  • The physiological role of ABCC1 and its interaction with endogenous hormones like ouabain remain largely unexplored.

Purpose of the Study:

  • To investigate the relationship between ouabain and the expression and function of ABCC1.
  • To establish a potential physiological role for ouabain in regulating ABCC1.

Main Methods:

  • Incubation of cells with varying concentrations and durations of ouabain.
  • Analysis of ABCC1 protein expression and mRNA levels.
  • Assessment of ABCC1 transporter activity using a fluorescent substrate (carboxyfluorescein diacetate).

Main Results:

  • Prolonged ouabain exposure (24 h) at 1 nmol/L or higher decreased ABCC1 protein expression while inducing its mRNA expression.
  • The observed decrease in ABCC1 protein was rapidly reversible upon removal of ouabain, indicating hormonal regulation.
  • Ouabain concentrations of 100 nmol/L or higher impaired ABCC1 activity, evidenced by increased carboxyfluorescein diacetate accumulation.

Conclusions:

  • Ouabain, as an endogenous hormone, regulates ABCC1 expression and function.
  • ABCC1 may be involved in hormonal regulation related to body volume control.
  • Findings suggest potential therapeutic implications for hypertensive cancer patients and highlight ABCC1's role in other tissues like the brain and immune system.

Related Concept Videos

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion, mediated...